Published in Am J Med on January 01, 1996
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev (2004) 2.95
Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial. Proc (Bayl Univ Med Cent) (2006) 2.26
Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 1.63
Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol (2004) 1.62
Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J Mol Diagn (2011) 1.41
Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model. PLoS One (2015) 1.40
Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol (2006) 1.31
Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis (2014) 1.28
Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan. J Clin Microbiol (2001) 1.26
Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol (2011) 1.26
Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. J Clin Microbiol (2003) 1.22
Clostridium difficile infection. Am J Med Sci (2010) 1.17
Antimicrobial resistance in hospitals: how concerned should we be? CMAJ (2009) 1.16
Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain (PCR ribotype 1). J Clin Microbiol (2005) 1.15
Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut (2004) 1.14
Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol (2008) 1.13
Clostridium difficile Infection and Inflammatory Bowel Disease: A Review. Gastroenterol Res Pract (2011) 1.11
Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study. BMJ (2012) 1.08
Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One (2013) 1.07
Bacterial contamination of inanimate surfaces and equipment in the intensive care unit. J Intensive Care (2015) 1.05
Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants. PLoS One (2011) 0.99
Clostridium difficile infection. Nat Rev Dis Prim (2016) 0.99
The A, B, BI, and Cs of Clostridium difficile. Clin Infect Dis (2009) 0.98
Clostridium: transmission difficile? PLoS Med (2012) 0.97
Hand hygiene--the case for evidence-based education. J R Soc Med (2001) 0.94
Effectiveness of motivational interviewing in promoting hand hygiene of nursing personnel. Int J Prev Med (2013) 0.94
The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge. Zoonoses Public Health (2010) 0.93
Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients. Antimicrob Agents Chemother (2015) 0.91
Aerial dissemination of Clostridium difficile spores. BMC Infect Dis (2008) 0.86
Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system. Clin Diagn Lab Immunol (2003) 0.86
Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic review. PLoS One (2013) 0.83
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis (2015) 0.82
Mapping urban malaria and diarrhea mortality in Accra, Ghana: evidence of vulnerabilities and implications for urban health policy. J Urban Health (2012) 0.81
A prospective study to examine the epidemiology of methicillin-resistant Staphylococcus aureus and Clostridium difficile contamination in the general environment of three community hospitals in southern Ontario, Canada. BMC Infect Dis (2012) 0.81
Comparison of restriction enzyme analysis, arbitrarily primed PCR, and protein profile analysis typing for epidemiologic investigation of an ongoing Clostridium difficile outbreak. J Clin Microbiol (1998) 0.79
Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS One (2015) 0.79
Pathogen transmission and clinic scheduling. Emerg Infect Dis (2006) 0.79
Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed. JAMA Intern Med (2016) 0.79
Assessment of contamination using an ATP bioluminescence assay on doorknobs in a university-affiliated hospital in Japan. BMC Res Notes (2015) 0.78
Culture-independence for surveillance and epidemiology. Pathogens (2013) 0.78
Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods. J Clin Microbiol (1999) 0.78
Environmental transmission of Clostridium difficile: association between hospital room size and C. difficile Infection. Infect Control Hosp Epidemiol (2015) 0.78
Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide study. Medicine (Baltimore) (2016) 0.78
Prevention and control of infections in the home. CMAJ (2009) 0.75
Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infection. PLoS One (2014) 0.75
The Antimicrobial Stewardship Approach to Combating Clostridium Difficile. Antibiotics (Basel) (2015) 0.75
A global theme issue: bibliography of references. Emerg Infect Dis (1997) 0.75
Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission. J Math Biol (2017) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis (1993) 7.60
Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet (1994) 6.47
Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet (2001) 5.90
Infections in patients with diabetes mellitus. N Engl J Med (1999) 5.39
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (1997) 4.28
Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis (1984) 4.10
Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med (1983) 3.97
Assessment and management of foot disease in patients with diabetes. N Engl J Med (1994) 3.83
Diphtheroid prosthetic valve endocarditis. A study of clinical features and infecting organisms. Am J Med (1980) 3.59
Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis (1995) 3.49
Prosthetic valve endocarditis. Analysis of 38 cases. Circulation (1973) 3.29
Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med (1981) 3.25
Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med (1999) 3.08
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med (1999) 2.56
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis (2001) 2.53
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol (2001) 2.31
Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29
Virulence of Staphylococcus aureus mutants altered in type 5 capsule production. Infect Immun (1991) 2.29
Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol (1994) 2.23
Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol (1993) 2.20
Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania. Int J Tuberc Lung Dis (2011) 2.19
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 2.15
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Epidemiologic and clinical utility of typing systems for differentiating among strains of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (1991) 2.09
Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA (1995) 2.09
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis (2003) 2.06
An outbreak of rubella among hospital personnel. N Engl J Med (1980) 2.05
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis (1998) 1.97
Clonal relationships among bloodstream isolates of Escherichia coli. Infect Immun (1995) 1.95
Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95
Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. Clin Infect Dis (1993) 1.92
Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis (1999) 1.83
Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting. J Clin Microbiol (1997) 1.82
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Enterococcal endocarditis: a comparison of prosthetic and native valve disease. Rev Infect Dis (1991) 1.77
Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J Clin Microbiol (1994) 1.73
Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun (1992) 1.67
Clinical features of microsporidiosis in patients with AIDS. Clin Infect Dis (1994) 1.65
Phyloproteomics: species identification of Enterobacteriaceae using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Mol Microbiol Biotechnol (2001) 1.65
Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med (1995) 1.64
Adequacy of fellowship training: results of a survey of recently graduated fellows. Clin Infect Dis (2001) 1.63
Late prosthetic valve endocarditis: clinical features influencing therapy. Am J Med (1978) 1.62
Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg (1977) 1.60
Staphylococcus aureus and vancomycin: the sequel. Ann Intern Med (1991) 1.59
Plasmid-pattern analysis for the differentiation of infecting from noninfecting Staphylococcus epidermidis. J Infect Dis (1984) 1.59
Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med (1990) 1.58
Evaluation of the AutoSCAN-3, a device for reading microdilution trays. J Clin Microbiol (1983) 1.56
Inhibition of lymphocyte mitogenesis by immobilized antigen-antibody complexes. J Exp Med (1975) 1.55
Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Am J Med (1985) 1.54
Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus. J Clin Microbiol (1990) 1.54
Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med (1987) 1.54
Relationship between indole production and differentiation of Klebsiella species: indole-positive and -negative isolates of Klebsiella determined to be clonal. J Clin Microbiol (1993) 1.53
Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med (1999) 1.53
Reactivity of type-specific monoclonal antibodies with Staphylococcus aureus clinical isolates and purified capsular polysaccharide. Infect Immun (1985) 1.51
Macrophage apoptosis in mycobacterial infections. J Leukoc Biol (1999) 1.51
Probing the conductance superposition law in single-molecule circuits with parallel paths. Nat Nanotechnol (2012) 1.49
Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile. J Clin Microbiol (1996) 1.46
Criteria for the diagnosis of infective endocarditis. Clin Infect Dis (1994) 1.44
Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg (1986) 1.44
Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother (2004) 1.42
Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol (1997) 1.40
Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis (1994) 1.38
Epidemiology of rubella. Am J Dis Child (1969) 1.38
Neurologic complications of bacterial endocarditis. Medicine (Baltimore) (1978) 1.36
Risk factors for the development of prosthetic valve endocarditis. Circulation (1985) 1.35
Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals. J Infect Dis (1997) 1.32
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Human lymphocyte alloantigen(s) similar to murine Ir region-associated (Ia) antigens. J Immunol (1975) 1.32
Comparative studies of rubella vaccines. Am J Dis Child (1969) 1.31
Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient. Clin Infect Dis (1992) 1.30
Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med (1984) 1.30
Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.29
Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis (1993) 1.26
Surveillance of mumps in the United States as background for use of vaccine. Public Health Rep (1968) 1.25
Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev Infect Dis (1986) 1.22
Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am (1995) 1.20
Detection of bacteremia with the BACTEC 16B resin blood culture medium. Am J Clin Pathol (1984) 1.17
Furazolidone in paediatric cholera. Bull World Health Organ (1970) 1.17
Characterization of IS1245 for strain typing of Mycobacterium avium. J Clin Microbiol (1998) 1.17
Temporal cluster of herpes simplex encephalitis: investigation by restriction endonuclease cleavage of viral DNA. J Infect Dis (1980) 1.17
Failure of quality control measures to prevent reporting of false resistance to imipenem, resulting in a pseudo-outbreak of imipenem-resistant Pseudomonas aeruginosa. J Clin Microbiol (1998) 1.16
Total hip arthroplasty in the treatment of adult hips with current or quiescent sepsis. J Bone Joint Surg Am (1981) 1.15